This included focal amplification of ERBB2 (chromosome 17) in tumour from patient 45, identified as amplifications (P1-P4) and gains in copy number (P5) across matched serial plasma (Fig. 3a, b). This evidence concerns the gene ERBB2 and neoplasm.